Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence?
- DOI
- 10.1080/14796694.2024.2426425
- Published
- 2025 Feb
- Container
- Future oncology (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2024.2426425,
title = {Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence?},
author = {Freedland SJ and Gleave M and De Giorgi U and Rannikko A and Pieczonka CM and Tutrone RF Jr and Venugopal B and Woo HH and Ramirez-Backhaus M and Tarazi J and Tang Y and Ganguli A and Haas GP and Shore ND},
year = {2025},
journal = {Future oncology (London, England)},
doi = {10.1080/14796694.2024.2426425},
url = {https://doi.org/10.1080/14796694.2024.2426425}
}RIS
TY - JOUR TI - Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence? AU - Freedland SJ AU - Gleave M AU - De Giorgi U AU - Rannikko A AU - Pieczonka CM AU - Tutrone RF Jr AU - Venugopal B AU - Woo HH AU - Ramirez-Backhaus M AU - Tarazi J AU - Tang Y AU - Ganguli A AU - Haas GP AU - Shore ND PY - 2025 JO - Future oncology (London, England) DO - 10.1080/14796694.2024.2426425 UR - https://doi.org/10.1080/14796694.2024.2426425 ER -
APA
SJ, F., M, G., U, D. G., A, R., CM, P., Jr, T. R., B, V., HH, W., M, R., J, T., Y, T., A, G., GP, H., & ND, S. (2025). Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence?. Future oncology (London, England). https://doi.org/10.1080/14796694.2024.2426425
Source records
- pubmed · retrieved 2026-09-26T13:16:42.248Z